Journal Watch
Does Incremental PD Preserve Residual Kidney Function?
Analysis of data from 154 patients in the randomized, controlled balANZ trial did not find a difference in the slope of ultrafiltration volume decline between full dose and incremental PD.
Read the abstract » | (added 2023-06-14)
Tags: Incremental PD, Residual Kidney Function, Ultrafiltration Volume
Meta-analysis of PD Remote Patient Monitoring
Analysis of data from 22 studies revealed that remote monitoring for PD reduced technique failure, hospitalization, and mortality vs. traditional PD monitoring.
Read the abstract » | (added 2023-04-19)
Tags: Remote Monitoring, PD, Technique Failure, Hospitalization, Mortality, Traditional PD Monitoring
How Kidney Patients Define Health
Among people with kidney failure who used three or more treatment options, “health” was linked to the ability to take part in meaningful activities and maintain life balance. Social and treatment environments that supported autonomy also helped people to consider themselves healthy.
Read the abstract » | (added 2023-04-19)
Tags: CKD, Treatment Options, Health, Treatment Experience, Shared Decision making
The Impact of Patient Empowerment on PD Self-management
A controlled trial investigated use of a problem-based learning (PBL) model to empower people on PD to self-manage. Among 94 participants, 47 patients were randomized to PBL learning, while the control group got usual care. PBL participants were divided into five study groups that each had six lessons. After 9-11.5 months, the PBL group had significantly more basic PD knowledge, higher self-management scores, better quality of life, increased satisfaction, and less depression and anxiety.
Read the abstract » | (added 2023-04-19)
Tags: Problem based Learning Model, PBL, Self management, PD Knowledge, Quality Of Life, Depression, Anxiety
Factors Linked with Time to First Peritonitis on PD
In a 5-year, 57 clinic, prospective randomized controlled trial in Europe, 33% of 671 participants had a bout of peritonitis. The factors independently linked with time to first peritonitis included older age, higher number of PD bags, low serum albumin, and higher body weight.
Read the abstract » | (added 2023-04-19)
Tags: Peritonitis, Age, PD Bags, Serum Albumin, Body Weight
Significant Racial Disparities Remain in Home Dialysis
A retrospective cohort study looking at nearly 1.1 million ESKD patients between 2006 and 2016 found that while mean rates of home dialysis increased, white patients still had higher home dialysis use (26.2% in 2016) than non-white patients (17.8%), nor have the racial disparities improved over time.
Read the abstract » | (added 2023-04-19)
Nephrologist Attitudes Toward Home Therapies Drive Practice
A survey of 327 nephrologists assessed their knowledge, attitudes, and practice around the choices for renal replacement therapy. Attitudes toward PD, HD, and transplant were independently linked to participants’ consideration of these options for patients.
Read the abstract » | (added 2023-04-19)
Tags: Nephrologists Modality Knowledge, Modality Bias, Choices For Renal Replacement Therapy, Modality Choice, Patient Education, Shared Decision making
5-year Assisted PD Program Outcomes
Not everyone can do solo PD—or has a partner. In BC, Canada, a pilot staff-assisted PD program began in 2016. Analysis of 5 years of data from 322 patients found growth to 11.2% of the total PD population, with a median time of 13.6 months on PD. More than 1/3 were able to use the service until they died.
Read the abstract » | (added 2023-02-13)
Serum Phosphorus and Survival on PD
Data from 5,847 PD patients between 2014-2017 from seven countries in the PDOPPS study found that compared to an optimal range of 3.5-4.5mg/dL, the hazard ratio (HR) for all-cause mortality was 19% higher when phosphorus was 5.5-6.5 and 53% higher when phosphorus was greater than 6.5. When 6 months of data were examined, the linkage was even stronger.
Read the abstract » | (added 2023-02-13)
Tags: PD, Serum Phosphorus, PDOPPS, Hazard Ratio, All cause Mortality
Do More Hours of HD Benefit Older Patients, Too?
Analysis of ANZDATA registry data of patients who started dialysis at age 65 and older from 2005 to 2015 say YES—hours of HD do matter to survival. Among 8,224 people, those whose HD sessions were 5 hours or longer had an 81% reduction in the hazard risk of death vs. those who only got 4-4.5 hour treatments (p < .001).
Read the abstract » | (added 2023-02-13)
Tags: HD, ANZDATA, HD Hours, Session Length, Survival Rate